
    
      By enrolling patients with multiple kinds of solid tumor adapted to enrolled criteria, this
      study will document for the first time the short/long term efficacy of auto/allogenic NK
      cells.The outcome will be evaluated according to local relief degree, progress free survival
      (PFS) and overall survival (OS).
    
  